← Back to patent-cliff list
CAS 504-29-0
pyridin-2-amine
Codes: ACAT-013, LORN-005
Application context (from source-drug indications)
Mantle cell lymphomaAcalabrutinibChronic lymphocytic leukaemiaAcalabrutinibLymphocytic leukaemiaAcalabrutinib风湿性疾病LornoxicamOsteoarthritisLornoxicam神经痛LornoxicamPostoperative painLornoxicamPainLornoxicam关节周围炎Lornoxicam
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Acalabrutinib | Tier A — Act now | 2030 |
| Lornoxicam | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-bromobenzoic acid→pyridin-2-amine→(4-(pyridin-2-ylcarbamoyl)phenyl)boronic acid→3-chloropyrazine-2-carbaldehyde→4-(amino(3-chloropyrazin-2-yl)methyl)-N-(pyridin-2-yl)benzamide→but-2-ynoyl-L-proline
methyl 2-(methyl-l2-azaneyl)acetate hydrochloride→methyl 5-chloro-3-(chlorosulfonyl)thiophene-2-carboxylate→methyl 5-chloro-3-(N-(2-methoxy-2-oxoethyl)-N-methylsulfamoyl)thiophene-2-carboxylate→methyl 6-chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide→pyridin-2-amine
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 2-Butynoic Acid Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 2-Butynoyl Chloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 3-Chloro-2-pyrazinemethanamine hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5 -a]pyrazin-3- yl)pyrrolidine-1-carboxylate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | [4-[(Pyridin-2-yl)carbamoyl]phenyl]boronic acid Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 4-[8-Amino-3-(2S)-2-pyrrolidinylimidazo[1,5 -a]pyrazin-1-yl]-N-2- pyridinylbenzamide Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.